| Recruiting | Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pre NCT07385807 | University of British Columbia | — |
| Not Yet Recruiting | Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA NCT07433946 | Lionhealth Srl Società Benefit | N/A |
| Not Yet Recruiting | Validation of PET Questionnaire for Experience and Sustainability in Telemedicine. PET(Patient Experience in T NCT07392606 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease NCT07300553 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Recruiting | A Randomised Paired Design Study of Texture and Colour Enhancement Imaging (TXI) Versus High-definition White NCT07271264 | London North West Healthcare NHS Trust | N/A |
| Recruiting | Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With NCT07224113 | Connecticut Children's Medical Center | — |
| Recruiting | Evaluation of the SMART IBD App in Pediatric IBD NCT07195123 | Children's Hospital Medical Center, Cincinnati | N/A |
| Not Yet Recruiting | Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveil NCT07208214 | London North West Healthcare NHS Trust | N/A |
| Not Yet Recruiting | Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD NCT07121920 | Cook Children's Health Care System | N/A |
| Not Yet Recruiting | Psychological Intervention for Fatigue in Inflammatory Bowel Diseases NCT06860009 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Recruiting | Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodph NCT07380022 | University of Thessaly | N/A |
| Not Yet Recruiting | Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD P NCT06772350 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Not Yet Recruiting | The Presence of Microplastics and Nanoplastics in the Humans Ileum, Colon, and Rectum and Their Relation With NCT06525558 | Pierpaolo Sileri | — |
| Not Yet Recruiting | Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or NCT07043036 | Resilience | Phase 3 |
| Recruiting | Impact of IBD Activity on Frailty in Patients Over 60 Years NCT06844318 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | — |
| Withdrawn | Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications NCT06224270 | University of Wisconsin, Madison | Phase 4 |
| Recruiting | Fluorescence Imaging of IBD and RA Using Adalimumab-800CW NCT03938701 | University Medical Center Groningen | Phase 2 |
| Recruiting | Immunological Characteristics of Preclinical IBD NCT05698745 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | — |
| Not Yet Recruiting | From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD NCT06227598 | Federico II University | — |
| Completed | Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease NCT06381518 | Zuyderland Medisch Centrum | N/A |
| Recruiting | Threonine Requirement in Adult Males With Crohn's Disease Using IAAO NCT04740541 | The Hospital for Sick Children | N/A |
| Recruiting | Ibd CAncer and seRious Infections in France (I-CARE 2) NCT06089590 | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | — |
| Unknown | Shared Decision Making in Paediatric Inflammatory Bowel Disease NCT05689892 | London Health Sciences Centre | N/A |
| Completed | Intestinal Epithelial Fucosylation Affects the Efficacy of Ustekinumab in Crohn's Disease NCT06203158 | Second Affiliated Hospital of Wenzhou Medical University | — |
| Unknown | Airway Involvement In Inflammatory Bowel Disease NCT06090045 | Assiut University | — |
| Not Yet Recruiting | From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD NCT06042582 | IRCCS San Raffaele | — |
| Completed | WPMDE1 - Whey Protein Milk-Derived Exosomes Among Healthy Subjects NCT06742203 | Exosomm Ltd. | N/A |
| Recruiting | The Assessment of Infrared Treatment for Crohn's Disease NCT06146816 | Shmuel Kivity, MD | N/A |
| Unknown | Role of 90K/Mac-2 BP as an Indicator of Early Response to Infliximab Therapy in IBD Patients NCT05960162 | Assiut University | — |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Recruiting | Vancomycin in Primary Sclerosing Cholangitis in Italy NCT05876182 | University of Milano Bicocca | Phase 2 |
| Withdrawn | 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients NCT05686135 | Jennifer Jones | N/A |
| Unknown | Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBD NCT05771363 | Assiut University | — |
| Completed | Efficacy and Safety of Lactulose for Bowel Preparation in Patients With Inflammatory Bowel Disease NCT05878639 | Second Affiliated Hospital of Wenzhou Medical University | N/A |
| Unknown | Inflammatory Bowel Disease Related Joint Manifestations NCT05693311 | Youstina Yosry Soliman | — |
| Unknown | The Gut Virome as a Trigger for IBD: From Metagenomics to Pathogenesis NCT05906680 | IRCCS San Raffaele | — |
| Unknown | San Raffaele IBD Biobank NCT06071572 | IRCCS San Raffaele | — |
| Completed | SMART-IBD App Trial NCT06023667 | Children's Hospital Medical Center, Cincinnati | N/A |
| Unknown | Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IB NCT05330299 | King's College London | N/A |
| Unknown | Prediction of IBD Disease Activity in Individual Patients Based on PROMs and Clinical Data NCT05578768 | Leiden University Medical Center | — |
| Completed | Boom-IBD Clinical Trial NCT05414955 | Boomerang Medical | N/A |
| Withdrawn | Biofeedback in Pediatric Inflammatory Bowel Disease NCT04269720 | Ross Maltz | N/A |
| Unknown | Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease NCT05246917 | IRCCS San Raffaele | N/A |
| Terminated | The Nori Health App NCT05474742 | UMC Utrecht | N/A |
| Recruiting | Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma NCT04902807 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Unknown | Prevalence of Chronic Abdominal Pain in Migraneurs NCT05086562 | Charite University, Berlin, Germany | — |
| Unknown | Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease NCT03935451 | McMaster University | EARLY_Phase 1 |
| Completed | Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients NCT05720221 | Helwan University | — |
| Unknown | Periodontal Therapy on the Gut Microbiome of Inflammatory Bowel Disease NCT04790825 | University of Turin, Italy | N/A |
| Unknown | Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients NCT04733456 | University of Calgary | — |
| Completed | Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease NCT04818892 | University of Wisconsin, Madison | — |
| Active Not Recruiting | Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease NCT04827368 | The Cleveland Clinic | — |
| Completed | Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomogr NCT04650867 | University of Erlangen-Nürnberg Medical School | — |
| Suspended | Methotrexate Polyglutamate Measurements in Patients With Inflammatory Bowel Disease NCT04205734 | Boston Children's Hospital | — |
| Unknown | Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt NCT04573400 | Assiut University | — |
| Unknown | Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases NCT05067959 | Rabin Medical Center | — |
| Unknown | Mental Health in Children and Youth Within Pediatric Care NCT04094324 | Region Skane | — |
| Suspended | Adjunctive Treatment With Vitamin D3 in Patients With Active IBD NCT04225819 | Massachusetts General Hospital | N/A |
| Recruiting | Pregnancy and Inflammatory Bowel Disease NCT07377188 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Effectiveness of PLENVU in the General Screening Population and Patients With IBD NCT04457934 | Johannes Gutenberg University Mainz | — |
| Completed | Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported A NCT04151420 | Maastricht University Medical Center | — |
| Completed | Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic NCT04344249 | Nantes University Hospital | — |
| Terminated | Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study NCT04296110 | Nationwide Children's Hospital | N/A |
| Terminated | Open-label Extension Study of Brazikumab in Crohn's Disease NCT03961815 | AstraZeneca | Phase 3 |
| Completed | Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) NCT04131504 | Children's Hospital Medical Center, Cincinnati | — |
| Unknown | The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States NCT03952364 | PredictImmune Ltd | — |
| Completed | Long-term Outcome of TNF Alpha Therapy in IBD NCT04575701 | Medical University of Graz | — |
| Completed | Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD NCT05997537 | Cedars-Sinai Medical Center | — |
| Terminated | An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn' NCT03759288 | AstraZeneca | Phase 2 / Phase 3 |
| Completed | Multiple Dose Ethnobridging PK Study in Healthy Subjects NCT03750565 | Theravance Biopharma | Phase 1 |
| Terminated | Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis NCT03616821 | AstraZeneca | Phase 2 |
| Completed | A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric NCT03466983 | Pharmacosmos A/S | Phase 4 |
| Completed | Phase 1 Food Effect Study for Alicaforsen Tablets NCT03473626 | Atlantic Pharmaceuticals Ltd | Phase 1 |
| Unknown | Estimating Indirect and OOP Costs in Pediatric Inflammatory Bowel Disease: a National Study NCT03522623 | University of Manitoba | — |
| Unknown | Immunological Profiles in Inflammatory Bowel Disease NCT03366090 | Rijnstate Hospital | — |
| Unknown | High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade NCT03162432 | Boston Children's Hospital | Phase 3 |
| Unknown | The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients NCT03145896 | Tel-Aviv Sourasky Medical Center | N/A |
| Active Not Recruiting | Bacterial Transmission In Utero and IBD Risk NCT03116568 | Chinese University of Hong Kong | — |
| Terminated | The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives NCT03291743 | Carilion Clinic | N/A |
| Unknown | Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease NCT02970149 | University of Manitoba | — |
| Completed | Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers NCT02914262 | Aerpio Therapeutics | Phase 1 |
| Completed | IBD Cancer and Serious Infection in Europe NCT02377258 | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | — |
| Unknown | Regulation of Vitamin D Metabolism by Washed Microbiota Transplantation in Patients With IBD NCT04989374 | The Second Hospital of Nanjing Medical University | — |
| Completed | Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Dise NCT02622139 | University of Erlangen-Nürnberg Medical School | N/A |
| Completed | Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis NCT02438410 | Mayo Clinic | — |
| Completed | Combination Therapy With Two Biologicals NCT05135221 | Tampere University Hospital | — |
| Completed | Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study NCT02364973 | Turku University Hospital | — |
| Completed | Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease NCT02536131 | Medical University of Vienna | N/A |
| Completed | Clinical and Molecular Phenotyping in IBD NCT02694588 | University Hospital Schleswig-Holstein | N/A |
| Completed | Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children NCT02182947 | Children's Mercy Hospital Kansas City | N/A |
| Recruiting | Stavanger University Hospital Inflammatory Bowel Disease Trial NCT01551563 | Helse Stavanger HF | — |
| Completed | Anal Dysplasia in Patients With Inflammatory Bowel Disease NCT01653054 | Montefiore Medical Center | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to NCT01369355 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease NCT02619552 | University of Maryland, Baltimore | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Croh NCT01369329 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Se NCT01369342 | Janssen Research & Development, LLC | Phase 3 |
| Unknown | IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. NCT02130349 | Maastricht University Medical Center | — |